177 related articles for article (PubMed ID: 10531390)
1. Binding pockets of the beta(1)- and beta(2)-adrenergic receptors for subtype-selective agonists.
Isogaya M; Sugimoto Y; Tanimura R; Tanaka R; Kikkawa H; Nagao T; Kurose H
Mol Pharmacol; 1999 Nov; 56(5):875-85. PubMed ID: 10531390
[TBL] [Abstract][Full Text] [Related]
2. Beta(1)-selective agonist (-)-1-(3,4-dimethoxyphenetylamino)-3-(3,4-dihydroxy)-2-propanol [(-)-RO363] differentially interacts with key amino acids responsible for beta(1)-selective binding in resting and active states.
Sugimoto Y; Fujisawa R; Tanimura R; Lattion AL; Cotecchia S; Tsujimoto G; Nagao T; Kurose H
J Pharmacol Exp Ther; 2002 Apr; 301(1):51-8. PubMed ID: 11907156
[TBL] [Abstract][Full Text] [Related]
3. The role of the seventh transmembrane region in high affinity binding of a beta 2-selective agonist TA-2005.
Kikkawa H; Isogaya M; Nagao T; Kurose H
Mol Pharmacol; 1998 Jan; 53(1):128-34. PubMed ID: 9443940
[TBL] [Abstract][Full Text] [Related]
4. Vascular responses to beta-adrenoceptor subtype-selective agonists with and without endothelium in rat common carotid arteries.
Chiba S; Tsukada M
J Auton Pharmacol; 2001 Feb; 21(1):7-13. PubMed ID: 11422573
[TBL] [Abstract][Full Text] [Related]
5. Domains of beta1 and beta2 adrenergic receptors to bind subtype selective agonists.
Kurose H; Isogaya M; Kikkawa H; Nagao T
Life Sci; 1998; 62(17-18):1513-7. PubMed ID: 9585128
[TBL] [Abstract][Full Text] [Related]
6. Functional beta1- and beta2-adrenoceptors in the left and right atrium of pre-hypertensive rats.
Doggrell SA
J Pharm Pharmacol; 2002 Oct; 54(10):1407-12. PubMed ID: 12396304
[TBL] [Abstract][Full Text] [Related]
7. Murine ventricular L-type Ca(2+) current is enhanced by zinterol via beta(1)-adrenoceptors, and is reduced in TG4 mice overexpressing the human beta(2)-adrenoceptor.
Heubach JF; Graf EM; Molenaar P; Jäger A; Schröder F; Herzig S; Harding SE; Ravens U
Br J Pharmacol; 2001 May; 133(1):73-82. PubMed ID: 11325796
[TBL] [Abstract][Full Text] [Related]
8. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
9. Constitutively active mutants of the beta1-adrenergic receptor.
Lattion A; Abuin L; Nenniger-Tosato M; Cotecchia S
FEBS Lett; 1999 Sep; 457(3):302-6. PubMed ID: 10471797
[TBL] [Abstract][Full Text] [Related]
10. Selective binding of ligands to beta 1, beta 2 or chimeric beta 1/beta 2-adrenergic receptors involves multiple subsites.
Marullo S; Emorine LJ; Strosberg AD; Delavier-Klutchko C
EMBO J; 1990 May; 9(5):1471-6. PubMed ID: 1970295
[TBL] [Abstract][Full Text] [Related]
11. Structural basis for the β-adrenergic receptor subtype selectivity of the representative agonists and antagonists.
Roy KK; Saxena AK
J Chem Inf Model; 2011 Jun; 51(6):1405-22. PubMed ID: 21534556
[TBL] [Abstract][Full Text] [Related]
12. Agonist interactions with chimeric and mutant beta1- and beta3-adrenergic receptors: involvement of the seventh transmembrane region in conferring subtype specificity.
Granneman JG; Lahners KN; Zhai Y
Mol Pharmacol; 1998 May; 53(5):856-61. PubMed ID: 9584211
[TBL] [Abstract][Full Text] [Related]
13. Role of adenylate and guanylate cyclases in beta1-, beta2-, and beta3-adrenoceptor-mediated relaxation of internal anal sphincter smooth muscle.
Li F; De Godoy M; Rattan S
J Pharmacol Exp Ther; 2004 Mar; 308(3):1111-20. PubMed ID: 14711933
[TBL] [Abstract][Full Text] [Related]
14. Ligand entry and exit pathways in the beta2-adrenergic receptor.
Wang T; Duan Y
J Mol Biol; 2009 Oct; 392(4):1102-15. PubMed ID: 19665031
[TBL] [Abstract][Full Text] [Related]
15. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
16. Relaxant effects of beta-adrenergic agonists on porcine and human detrusor muscle.
Badawi JK; Uecelehan H; Hatzinger M; Michel MS; Haferkamp A; Bross S
Acta Physiol Scand; 2005 Oct; 185(2):151-9. PubMed ID: 16168009
[TBL] [Abstract][Full Text] [Related]
17. Binding of a catechol derivative of denopamine (T-0509) and N-tert-butylnoradrenaline (Colterol) to beta 1- and beta 2-adrenoceptors.
Kusayama T; Oka J; Yabana H; Adachi-Akahane S; Nagao T
Biol Pharm Bull; 1994 Aug; 17(8):1023-7. PubMed ID: 7820101
[TBL] [Abstract][Full Text] [Related]
18. The unique nature of the serine interactions for alpha 1-adrenergic receptor agonist binding and activation.
Hwa J; Perez DM
J Biol Chem; 1996 Mar; 271(11):6322-7. PubMed ID: 8626427
[TBL] [Abstract][Full Text] [Related]
19. Functional and binding characteristics of long-acting beta 2-agonists in lung and heart.
Roux FJ; Grandordy B; Douglas JS
Am J Respir Crit Care Med; 1996 May; 153(5):1489-95. PubMed ID: 8630591
[TBL] [Abstract][Full Text] [Related]
20. A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors.
Summerhill S; Stroud T; Nagendra R; Perros-Huguet C; Trevethick M
J Pharmacol Toxicol Methods; 2008; 58(3):189-97. PubMed ID: 18652905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
